2      0

ISHLTv Recorded Webinars

ISHLTv_16 - All Mod Cons: Right Heart Catheterization Pearls and Gems in Pulmonary Hypertension


May 26, 2021 3:00pm ‐ May 26, 2021 4:00pm


Members: Free

Description

Summary:
Right heart catheterization is the gold standard for the assessment of pulmonary hypertension. It is critical at different steps in the differential diagnosis and the distinction between post and pre-capillary Pulmonary Hypertension. It also provides insights on outcome and is an important guide for treatment decisions in pulmonary vascular diseases (PAH and CTEPH) and in advanced heart failure (MCS and HTX). Although widely used in clinical practice, right heart catheterization requires specific knowledge both in data collection and interpretation of results. This webinar will cover some challenging situations illustrating the importance of invasive hemodynamic assessment in advances cardiac and respiratory conditions.

Moderators:
Ioana Preston, MD, and Jaime Hernandez-Montfort, MD

Absolute Beginners: Right Heart Catheterization in Pre-capillary Pulmonary Hypertension
Colin Church, BSC(Hons), PhD, FRCP, Golden Jubilee National Hospital, Glasgow, UK

This talk will cover the importance of RHC in the evaluation of pre-capillary PH and discuss how invasive HD is integrated in the assessment of severity in PAH/CTEPH

A Town Called Malice: What is the Wedge? Invasive Hemodynamics in Advanced Heart Failure
Ryan Tedford, MD, Medical University of South Carolina (MUSC), Charleston, SC, USA

The distinction between pre and post capillary PH is based on PAWP, a single pressure measurement. As simple as it seems, this measurement may be difficult to record (when, how). This talk will discuss technical issues, what are the normal values and how to interpret PAWP in patients with heart failure.

Going Underground: Can This Patient Be Weaned From LVAD?
Emma Birks, MD, University of Kentucky, Lexington, KY, USA

There is growing evidence that patients implanted with a LVAD may safely be weaned from the device. Although no specific protocol has been accepted, many centers use RHC at rest or during exercise for decision-making purposes. This talk will cover the role of RHC in identifying patients in whom weaning may be considered.

That’s Entertainment: Testing Vasoreactivity in Pulmonary Hypertension
Celine Dewachter, MD, PhD, Erasme Hospital, Brussels, Belgium

Pulmonary hypertension is a hemodynamic condition. In some specific clinical situations, PH may be reversed even in the presence of disturbed hemodynamics. This talk will discuss the role of vasoreactivity testing in PAH, left heart disease and MCS/heart transplantation.

Live Q&A with All Speakers
Led by Moderators


ISHLT Announcements
Greg Schultz
, ISHLT CEO


ISHLTv Webinar: All Mod Cons: RHC Pearls and Gems in Pulmonary Hypertension Enduring Materials
Date of CE Release: June 3, 2021
Date of CE Expiration: June 2, 2022
Location: Online

Acknowledgement of Financial and/or In-Kind Commercial Support
No financial or in-kind commercial support was received for this educational activity.

Satisfactory Completion
Learners must complete an evaluation form to receive a certificate of completion. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.

Physicians
Accreditation Statement - The International Society for Heart and Lung Transplantation (ISHLT) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation Statement - ISHLT designates this live virtual activity for 1.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Accreditation Statement
custom imageIn support of improving patient care, this activity has been planned and implemented by Amedco LLC and the International Society for Heart & Lung Transplantation. Amedco LLC is jointly accredited by the American Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Nurses (ANCC) Credit Designation
Amedco LLC designates this live virtual activity for 1.00 ANCC contact hours for nurses.

Transplant Coordinators
As a designated Approved Provider by the American Board for Transplant Certification (ABTC), the International Society for Heart and Lung Transplantation grants up to 1.00 Category 1 Continuing Education Points for Transplant Coordinators (CEPTCs) for this offering. CEPTC Approval Number: 221-29.

Nurse Practitioners
The American Association of Nurse Practitioners (AANP) recognizes the Accreditation Council for Continuing Medical Education (ACCME) and the American Nurses Credentialing Center (ANCC) as approved accreditors and allow reciprocity for AANPCP continuing education credit.

Objectives - After Participating in This Program You Should Be Able To:
1. Discuss the importance of RHC in the evaluation of pre capillary PH
2. Explain how invasive HD is integrated in the assessments of severity in PAH/CTEPH
3. Identify the distinction between pre and post capillary PH is based on PAWP: A single pressure measurement
4. Describe the role of RHC in identifying patients in whom weaning may be considered
5. Recognize the role of vasoreactivity testing in PAH, left heart disease and MCS/HTX

Disclosure of Conflict of Interest
The following table of disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content disclosed to Amedco. All of these relationships were treated as a conflict of interest, and have been resolved. (C7 SCS 6.1-­‐6.2, 6.5)

All individuals in a position to control the content of CE are listed below.

First Name

Last Name

Commercial Interest:Relationship

Emma

Birks

No disclosures

Colin

Church

Honoraria: Jannsen, MSD, Actellion; Travel Grants: Jannsen, MSD, Actelion

Jenny

Clark

No disclosures

Celine

Dewachter

No disclosures

Jaime   

Hernandez-Montfort

No disclosures

Sheryl

Morgan

No disclosures

Iona

Preston

Actelion, Acceleron, Bayer, Complexa, Gilead, United Therapeutics, Tenas, Phasebo, Liquidia:Research Grant Site Principal Investigator,Actelion, Gilead, Respira, Pfizer:Consultant,Acceleron, Liquidia:Scientific/Medical Advisory Board Member

Greg

Schultz

No disclosures

Ryan

Tedford

Medical Advisory Board: Metronic, Abbott, Acceleron;Abiomed, Hemodynamic Core Lab: Merck, Actelion; Consultant: Medtronic, Abbott, Itamar, United Therapeutics, Eidos Therapeutics, Gradient, Edwards LifeSciences, Aria CV, Arena Pharmeceuticals, Lexicon Pharmaceuticals.

How to Get Your Certificate

  1. Go to http://workshop-evaluator.herokuapp.com/evaluation/9026
  2. Evaluate the meeting.
  3. Print all pages of your certificate for your records.

Questions? Email Certificate@AmedcoEmail.com

Speaker(s):

  • Ioana R. Preston, MD, Boston, MA, USA, Tufts Medical Center
  • Jaime Hernandez-Montfort, MD, MPH, Austin, TX, USA, Baylor Scott & White Health
  • Colin Church, MRCP, Consultant in Pulmonary Vascular and Respiratory Medicine<br>Glasgow, UK<p></p>, Golden Jubilee National Hospital
  • Ryan Tedford, MD, Charleston, SC, USA<p></p>, Medical University of South Carolina
  • Emma J. Birks, MD, PhD, Lexington, KY, USA, University of Kentucky
  • Celine Dewachter, MD, PhD, Brussels, Belgium<p></p>, Erasme Hospital
  • Greg Schultz, CEO<br>Addison, TX, USA<p></p>, International Society for Heart and Lung Transplantation

You must be logged in and own this session in order to post comments.